Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.

Veronika Rachar; Martin Czejka; Marie Kitzmueller; Philipp Buchner; Maria Lichtneckert; Richard Greil; Herbert Geiler; Christian Dittrich

doi:10.21873/anticanres.11026

Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.

Veronika Rachar
, Martin Czejka
, Marie Kitzmueller
, Philipp Buchner
, Maria Lichtneckert
, Richard Greil (Co-Autor/-in)
, Herbert Geiler
, Christian Dittrich

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

6 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	4715-4723
Fachzeitschrift	ANTICANCER RESEARCH
Jahrgang	36
Ausgabenummer	9
DOIs	https://doi.org/10.21873/anticanres.11026
Publikationsstatus	Veröffentlicht - 2016

Zugriff auf Dokument

10.21873/anticanres.11026

Dieses zitieren

Rachar, V., Czejka, M., Kitzmueller, M., Buchner, P., Lichtneckert, M., Greil, R., Geiler, H., & Dittrich, C. (2016). Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients. ANTICANCER RESEARCH , 36(9), 4715-4723. https://doi.org/10.21873/anticanres.11026

Rachar, Veronika ; Czejka, Martin ; Kitzmueller, Marie et al. / Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients. in: ANTICANCER RESEARCH 2016 ; Jahrgang 36, Nr. 9. S. 4715-4723.

@article{8e98d4e426e24fc190b48f663fba4f90,

title = "Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.",

keywords = "GROWTH-FACTOR RECEPTOR, PLASMA DISPOSITION, METABOLITES, CHEMOTHERAPY, QUANTIFICATION, ANGIOGENESIS, COMBINATION, IRINOTECAN, ONCOLOGY, ANTIBODY",

author = "Veronika Rachar and Martin Czejka and Marie Kitzmueller and Philipp Buchner and Maria Lichtneckert and Richard Greil and Herbert Geiler and Christian Dittrich",

note = "Greil: Paracelsus Med Univ Salzburg, Dept Med 3, Salzburg, Austria;",

year = "2016",

doi = "10.21873/anticanres.11026",

language = "English",

volume = "36",

pages = "4715--4723",

journal = "ANTICANCER RESEARCH ",

issn = "0250-7005",

number = "9",

}

Rachar, V, Czejka, M, Kitzmueller, M, Buchner, P, Lichtneckert, M, Greil, R, Geiler, H & Dittrich, C 2016, 'Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.', ANTICANCER RESEARCH , Jg. 36, Nr. 9, S. 4715-4723. https://doi.org/10.21873/anticanres.11026

Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients. / Rachar, Veronika; Czejka, Martin; Kitzmueller, Marie et al.
in: ANTICANCER RESEARCH , Jahrgang 36, Nr. 9, 2016, S. 4715-4723.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients.

AU - Rachar, Veronika

AU - Czejka, Martin

AU - Kitzmueller, Marie

AU - Buchner, Philipp

AU - Lichtneckert, Maria

AU - Greil, Richard

AU - Geiler, Herbert

AU - Dittrich, Christian

N1 - Greil: Paracelsus Med Univ Salzburg, Dept Med 3, Salzburg, Austria;

PY - 2016

Y1 - 2016

KW - GROWTH-FACTOR RECEPTOR

KW - PLASMA DISPOSITION

KW - METABOLITES

KW - CHEMOTHERAPY

KW - QUANTIFICATION

KW - ANGIOGENESIS

KW - COMBINATION

KW - IRINOTECAN

KW - ONCOLOGY

KW - ANTIBODY

U2 - 10.21873/anticanres.11026

DO - 10.21873/anticanres.11026

M3 - Original Article

C2 - 27630318

SN - 0250-7005

VL - 36

SP - 4715

EP - 4723

JO - ANTICANCER RESEARCH

JF - ANTICANCER RESEARCH

IS - 9

ER -

Rachar V, Czejka M, Kitzmueller M, Buchner P, Lichtneckert M, Greil R et al. Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients. ANTICANCER RESEARCH . 2016;36(9):4715-4723. doi: 10.21873/anticanres.11026